BTG2: a rising star of tumor suppressors (review)

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• B-cell translocation gene 2 (BTG2) is a tumor suppressor involved in cell differentiation, proliferation, DNA repair, and apoptosis.
• BTG2 expression is frequently downregulated in human cancers, suggesting a role in carcinogenesis.
• The precise regulatory mechanisms controlling BTG2 expression remain largely unelucidated.

Purpose of the Study:

• To review the biological functions of BTG2 in cancer cells.
• To summarize recent findings on the regulation of BTG2 expression.
• To highlight the role of microRNA-21 (miR-21) in modulating BTG2 gene expression across various cancers.

Main Methods:

• Literature review of studies investigating BTG2 function and regulation.
• Analysis of research focusing on microRNA interactions with BTG2.
• Synthesis of data on BTG2's role in different human cancer types.

Main Results:

• BTG2 exhibits diverse biological activities, including antiproliferative effects, functioning as a tumor suppressor.
• MicroRNAs, particularly miR-21, have emerged as significant regulators of BTG2 expression.
• Dysregulation of the miR-21/BTG2 axis is implicated in the development and progression of common human cancers.

Conclusions:

• BTG2 plays a critical role in tumor suppression through its involvement in fundamental cellular processes.
• MicroRNA-mediated regulation, especially by miR-21, is a key mechanism influencing BTG2 levels in cancer.
• Understanding the miR-21-BTG2 interaction offers potential therapeutic strategies for cancer treatment.